We found that treatment of breast cancer cells in vitro with DON, an inhibitor of several glutamine utilizing enzymes, phenocopied the effects of glutamine deprivation and led to an increase in G-CSF and GM-CSF expression. Here, CSF2 is linked to breast carcinoma.